Loading Events

« All Events

  • This event has passed.

Biotech Development Lab 2019 – Formula for Success

September 13 @ 8:45 am - 5:00 pm AEST

In collaboration with the Medicines Manufacturing Innovation Centre, Biotech Development Lab is back for 2019 with a range of engaging topics and expert speakers. The one day symposium – Formula for Success – will focus on drug discovery and development, overcoming obstacles in the production pipeline, and opportunities that exist for industry collaboration, funding and progression.

The development of new innovative medicines is essential for health and transforming healthcare, but there can be many challenges along the way. The formulation process of drug development is critical to success, however achieving optimal formulation can be challenging. The success of clinical trials and commercialisation of a product is dependent on the drug development pathway, and specifically formulation of a drug, and so getting this right is essential. Even with an active compound and a plan for human trials, without the right formulation you could waste time, resources and money along the way.

Our speakers will explore a range of strategies and technologies to develop more efficient drug formulation pipelines – to assist with more effective drug designs and drug deliveries, overcoming formulation challenges, and most importantly how to manage risk along the way. With backgrounds from both academia and industry, and roles across the drug development program, our expert speakers will demonstrate how important a development programme is for achieving better patient outcomes with less wasted resources, time and money along the way.

Click here to view the full agenda and presentation titles

Session 1: Accelerating drug discovery and development through collaborations:  This session will provide perspectives on industry and academia collaborations and business aspects of building sound commercial strategies. How to deliver efficient, cost effective and timely results in drug development. How to collaborate and share non-competitive data and look for new ways to share knowledge. What worked and what didn’t and what were the lessons learned.

Session 2: Overcoming bioavailability hurdles – developing novel drug delivery systems to improve clinical efficacy:  What are the challenges in drug delivery? How can developing novel drug delivery solutions overcome some delivery challenges and what are the benefits of targeted drug delivery? Can R&D help industry to move on from one-drug-fits-all scenarios and help offer the right treatment and the right dose to give a more targeted, efficient therapy?

Session 3: Lab to production – controlling the process: Formulation and manufacturing processes can help with efficiency and scalability. Good formulations need to be manufacturable, chemically and physically stable and bioavailable. What are the challenges for formulation, development & scale-up, R&D to production, design and validation? What are the pre-formulation strategies that can improve efficiency and keep the process on time and on budget?

Session 4: From research to commercialisation – who pays?: This session will provide perspectives on the funding of medical research and translation and where to find support. Themes explored in the panel session will focus on funding models and available grants and what are the opportunities of collaborative funding arrangements between industry, government and philanthropy. How can we translate academic science to industry and what is the changing nature of medical research funding?

Session 5: Networking

Speakers include:

  • State Government of Victoria, Department of Jobs, Precincts and Regions- Andrew Wear, Director, Medical Technologies and Pharmaceuticals
  • Bristol-Myers Squibb, Dr Jamie Lopez, Senior Medical Science Liason
  • Inhaled Oxytocin Project, Monash Institute of Pharmaceutical Sciences – Dr Victoria Oliver, Project Coordinator
  • Monash Institute of Pharmaceutical Sciences – Dr Sherie Ma, Research Fellow, Molecular & Translational Drug Discovery, Servier Program in Drug Discovery & Co-Founder, Somnivore
  • Novartis, Australia & New Zealand – Simon Fisher, Chief Scientific Officer
  • Vifor Pharma Pty Ltd – James McDonnell, Vice President, General Manager, Vifor Pharma Australia and New Zealand
  • ARC Centre of Excellence in Convergent Bio-Nano Science and Technology and Monash Institute of Pharmaceutical Sciences – Dr Anna Cifuentes Rius, Research Fellow
  • ARC Centre of Excellence in Convergent Bio-Nano Science & Technology – Dr Nicholas Veldhuis, Project Leader – Endosomal Signalling
  • Monash Institute of Pharmaceutical Sciences and Faculty of Pharmacy and Pharmaceutical Sciences at Monash University – Dr Natalie Trevaskis, Senior Lecturer, Drug Delivery Disposition & Dynamics
  • Formulytica – Dr Richard Buchta, CEO
  • Lonza Pharma Biotech & Nutrition – Dr Hywel Williams, Senior Principal Scientist
  • Pfizer – Julie Liu, R&D Operational and CMC Excellence
  • National Foundation for Medical Research and Innovation – Dr Noel Chambers, Chief Executive Officer
  • Monash University – Dr Karen McConalogue, Director, Medical Research Future Fund and Major Research Initiatives
  • Inhaled Oxytocin Project, Monash Institute of Pharmaceutical Sciences – Pete Lambert, Senior Project Manager
  • LaunchVic – Kate Cornick,CEO

Sessions chaired by:

  • Watermark – Karen Sinclair, Principal, Patent & Trade Marks Attorney
  • SeerPharma – Louise White, Partner & Senior Consultant
  • Biocurate – Dr Catherine Drinkwater, Director of Project Management,
  • Department of Industry, Innovation & Science; AusIndustry – Innovation Programmes; Accelerating Commercialisation – Stephen Goodall, Commercialisation Adviser

Our funding panel will discuss the changing nature of medical research funding towards outcomes of impact and commercialisation and explore the opportunities of collaborative funding arrangements between industry, government and philanthropy.

 

 

 

 

 

 

 

 

 

Format: Sessions including keynote speakers, panel speakers, case studies
Outcomes: New insights, new business contacts, greater understanding of the formulation process and drug delivery technologies, new knowledge to inform business strategy, new collaborations and partnerships, increased awareness of local business capabilities.
Who should attend: Biotech and pharma executives, industry professionals, business leaders, entrepreneurs, investors, clinicians, researchers, product developers and industry experts across biotechnology, pharmaceuticals and health innovation.

When: Friday 13th September 2019  Schedule: Registration and pre-event networking from 8.15am  Official event opening: 8.45am  Program sessions: 9.00am – 5.00pm, followed by networking drinks until 6.00pm.
Where: Lecture Theatre B, Level 7, Peter MacCallum Cancer Centre @ VCCC, 305 Grattan Street, Melbourne
Price:  We have been able to keep prices the same as event last year thanks to the fabulous support from our sponsors.
$295 – Members
$550 – Non Members
(Prices include GST)

To check if your organisation is a member click  here

Cancellation Policy:
A full refund is given up to 7 days prior to the event, no refunds within 7 days of the event.

With thanks to our event sponsors:

 

Brought to you by:

Details

Date:
September 13
Time:
8:45 am - 5:00 pm
Cost:
$295 - $550
Event Category:

Contact

BioMelbourne Network
Phone:
+61 3 9667 8181
Email:
info@biomelbourne.org

Home

News & opinion

Member Directory

Events